Annual ROE
-31.16%
-20.33%-187.72%
December 31, 2024
Summary
- As of March 9, 2025, ARCT annual return on equity is -31.16%, with the most recent change of -20.33% (-187.72%) on December 31, 2024.
- During the last 3 years, ARCT annual ROE has risen by +34.04% (+52.21%).
- ARCT annual ROE is now -111.19% below its all-time high of 278.48%, reached on December 31, 2012.
Performance
ARCT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-31.04%
-7.72%-33.10%
December 31, 2024
Summary
- As of March 9, 2025, ARCT quarterly return on equity is -31.04%, with the most recent change of -7.72% (-33.10%) on December 31, 2024.
- Over the past year, ARCT quarterly ROE has dropped by -4.71% (-17.89%).
- ARCT quarterly ROE is now -112.62% below its all-time high of 246.03%, reached on March 31, 2013.
Performance
ARCT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ARCT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -187.7% | -17.9% |
| 3 y3 years | +52.2% | +58.2% |
| 5 y5 years | +76.4% | +58.2% |
ARCT ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -930.9% | +52.2% | -161.4% | +58.4% |
| 5 y | 5-year | -930.9% | +76.4% | -161.4% | +77.1% |
| alltime | all time | -111.2% | +92.2% | -112.6% | +77.1% |
Arcturus Therapeutics Holdings ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -31.16%(+187.7%) | -31.04%(+33.1%) |
| Sep 2024 | - | -23.32%(-11.4%) |
| Jun 2024 | - | -26.33%(-29.5%) |
| Mar 2024 | - | -37.33%(+262.4%) |
| Dec 2023 | -10.83%(-388.8%) | -10.30%(-127.2%) |
| Sep 2023 | - | 37.90%(+13.4%) |
| Jun 2023 | - | 33.42%(-33.9%) |
| Mar 2023 | - | 50.55%(+980.1%) |
| Dec 2022 | 3.75%(-105.8%) | 4.68%(-106.3%) |
| Sep 2022 | - | -74.19%(+3.0%) |
| Jun 2022 | - | -72.04%(-3.4%) |
| Mar 2022 | - | -74.60%(+13.0%) |
| Dec 2021 | -65.20%(+90.8%) | -66.04%(+6.1%) |
| Sep 2021 | - | -62.24%(+7.6%) |
| Jun 2021 | - | -57.82%(+9.2%) |
| Mar 2021 | - | -52.94%(+16.6%) |
| Dec 2020 | -34.17%(-74.1%) | -45.41%(-24.3%) |
| Sep 2020 | - | -59.98%(-39.6%) |
| Jun 2020 | - | -99.28%(-26.7%) |
| Mar 2020 | - | -135.43%(+7.7%) |
| Dec 2019 | -131.82%(+43.5%) | -125.80%(+44.0%) |
| Sep 2019 | - | -87.35%(+0.1%) |
| Jun 2019 | - | -87.23%(-32.3%) |
| Mar 2019 | - | -128.87%(+39.2%) |
| Dec 2018 | -91.85% | -92.57%(+2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -90.01%(+26.0%) |
| Jun 2018 | - | -71.45%(+66.6%) |
| Mar 2018 | - | -42.90%(+4.1%) |
| Dec 2017 | -61.64%(+1291.4%) | -41.23%(-257.1%) |
| Sep 2017 | - | 26.24%(+122.9%) |
| Jun 2017 | - | 11.77%(<-9900.0%) |
| Mar 2017 | - | -0.01%(-99.7%) |
| Dec 2016 | -4.43%(+4.0%) | -3.16%(-70.4%) |
| Sep 2016 | - | -10.67%(+147.0%) |
| Jun 2016 | - | -4.32%(+24.1%) |
| Mar 2016 | - | -3.48%(-12.8%) |
| Dec 2015 | -4.26%(-97.4%) | -3.99%(-94.2%) |
| Sep 2015 | - | -68.34%(-30.1%) |
| Jun 2015 | - | -97.76%(-12.4%) |
| Mar 2015 | - | -111.58%(+5.0%) |
| Dec 2014 | -164.64%(+660.1%) | -106.28%(+27.5%) |
| Sep 2014 | - | -83.34%(+23.8%) |
| Jun 2014 | - | -67.30%(+22.7%) |
| Mar 2014 | - | -54.84%(+53.5%) |
| Dec 2013 | -21.66%(-107.8%) | -35.73%(-8.9%) |
| Sep 2013 | - | -39.21%(+77.7%) |
| Jun 2013 | - | -22.06%(-109.0%) |
| Mar 2013 | - | 246.03%(+37.0%) |
| Dec 2012 | 278.48%(-169.8%) | 179.54% |
| Dec 2011 | -398.88% | - |
FAQ
- What is Arcturus Therapeutics Holdings annual return on equity?
- What is the all time high annual ROE for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual ROE year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly return on equity?
- What is the all time high quarterly ROE for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly ROE year-on-year change?
What is Arcturus Therapeutics Holdings annual return on equity?
The current annual ROE of ARCT is -31.16%
What is the all time high annual ROE for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual return on equity is 278.48%
What is Arcturus Therapeutics Holdings annual ROE year-on-year change?
Over the past year, ARCT annual return on equity has changed by -20.33% (-187.72%)
What is Arcturus Therapeutics Holdings quarterly return on equity?
The current quarterly ROE of ARCT is -31.04%
What is the all time high quarterly ROE for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly return on equity is 246.03%
What is Arcturus Therapeutics Holdings quarterly ROE year-on-year change?
Over the past year, ARCT quarterly return on equity has changed by -4.71% (-17.89%)